Bladder Cancer Progression Despite BCG Therapy Predicts Worse Outcomes
Progression on bacillus Calmette-Guérin (BCG) likely represents a biologically aggressive disease state as well as diagnostic delay, according to investigators.
Chemotherapy
Taxane-Containing Chemo Associated With Persistent Alopecia
However, many patients experience improvements in hair density with standard alopecia treatments
Neoadjuvant Chemo May Improve Outcomes for MIBC of Variant Histology
Findings refute the notion that variant histology MIBC will not respond to neoadjuvant chemotherapy.
Older Adults May Benefit From NAC Prior to UTUC Radical Surgery
Neoadjuvant chemotherapy prior to radical nephroureterectomy for upper tract urothelial carcinoma may improve pathologic outcomes regardless of age, new data suggest.
First-Line Immunotherapy, Chemotherapy for mUC of the Bladder Offer Similar Survival
Real-world data validate recently reported findings from clinical trials.
Study: Race-Free CKD-EPI Equation Undercuts Cancer Therapy in Black Patients
Accurate kidney function assessment is a crucial consideration when prescribing a patient’s anticancer therapy regimen.
Adjuvant Nivolumab Improves Outcomes in High-Risk Urothelial Carcinoma
Nivolumab treatment for patients who have undergone radical surgery for high-risk muscle-invasive urothelial carcinoma improves their disease-free survival compared with placebo, a study shows.
Algorithm Proposed to Expand Cisplatin Eligibility for MIBC
A new algorithm developed by Canadian investigators aims to address underuse of cisplatin-based chemotherapy for muscle-invasive bladder cancer.
Radiation for Abdominal, Pelvic Cancers Ups Secondary Sarcoma Risk
Compared with patients who undergo surgery alone for abdominal or pelvic cancers, those who receive radiation and chemotherapy are at elevated risk for secondary sarcomas.
How Cancer Care Can Affect the Kidney
Recent advances in cancer management may present challenges for nephrologists.
- Loading...
Loading...
Next post in Acute Kidney Injury
Loading... 
Loading...